Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Tiny microRNAs help destroy unwanted messenger RNAs in cells. New research finds how the body keeps them in check.
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.
Using these new particles, researchers could develop treatments for heart disease and other conditions.
Findings related to bacterial gene expression overturn fundamental assumptions about basic biological pathways.
ENCODE consortium identifies RNA sequences that are involved in regulating gene expression.
Unique survey of gene expression by cell type in humans and mice reveals several deficits affecting the most vulnerable neurons.
Using engineered binder proteins to detect viral proteins or antibodies rather than RNA, new tests may overcome current challenges in testing for SARS-CoV-2 virus.
Applied computational biology discoveries vastly expand the range of CRISPR’s access to DNA sequences.
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.
Chemical engineer aims to create a test that can work in 10 minutes and doesn’t require specialized instruments or laboratory infrastructure.
Researchers develop a method to isolate and sequence the RNA of T cells that react to a specific target.
Whitehead Institute member and assistant professor of biology receives one of the most prestigious non-governmental awards for early-career scientists.
Vaccines packaged in novel nanoparticles could offer a new way to fight cancer and infectious diseases.
Whitehead Institute scientists find chemical modification contributes to trafficking between non-membrane-bound compartments that control gene expression.